Emmaus Life Sciences, Inc.
EMMA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000822370
In the last 90 days, Emmaus Life Sciences, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of EMMA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Emmaus Life Sciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Lim Seah H. | 13G/A | 6.50%4.15M shares | – | Feb 4, 20251 filing | Feb 4, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Emmaus Life Sciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 4, 202511:00 AM ET | Lim Seah H. | 13G/A | 6.50%4.15M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Emmaus Life Sciences, Inc. shares.
No Form 144 notices for Emmaus Life Sciences, Inc. are on file.